Wang, L., Yu, X., Wang, C., Pan, S., Liang, B., Zhang, Y., . . . Li, B. (2017). The anti-ErbB2 antibody H2-18 and the pan-PI3K inhibitor GDC-0941 effectively inhibit trastuzumab-resistant ErbB2-overexpressing breast cancer. Oncotarget.
استشهاد بنمط شيكاغوWang, Lingfei, et al. "The Anti-ErbB2 Antibody H2-18 and the Pan-PI3K Inhibitor GDC-0941 Effectively Inhibit Trastuzumab-resistant ErbB2-overexpressing Breast Cancer." Oncotarget 2017.
MLA استشهادWang, Lingfei, et al. "The Anti-ErbB2 Antibody H2-18 and the Pan-PI3K Inhibitor GDC-0941 Effectively Inhibit Trastuzumab-resistant ErbB2-overexpressing Breast Cancer." Oncotarget 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.